Jiagui Song, Zhengyang Guo, Decao Yang, Ping Yu, Yinjia Li, Zhuhui Yuan et al. Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS–STING–STAT3 survival axis. // Clinical and Translational Medicine. – 2026. – DOI: 10.1002/ctm2.70885. – URL: https://onlinelibrary.wiley.com/doi/10.1002/ctm2.70885?af=R
Jiagui Song, Zhengyang Guo, Decao Yang, Ping Yu, Yinjia Li, Zhuhui Yuan, Xiaojuan Ma, Xianlong Li, Hongyan Guo, Lixiang Xue, & Tong Liu (2026). Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS–STING–STAT3 survival axis. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70885
Jiagui Song, et al. “Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS–STING–STAT3 survival axis.” Clinical and Translational Medicine, 2026. doi:10.1002/ctm2.70885.
@article{Song2026,
title = {Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS–STING–STAT3 survival axis},
author = {Song, Jiagui and Guo, Zhengyang and Yang, Decao and Yu, Ping and Li, Yinjia and Yuan, Zhuhui and Ma, Xiaojuan and Li, Xianlong and Guo, Hongyan and Xue, Lixiang and Liu, Tong},
journal = {Clinical and Translational Medicine},
year = {2026},
doi = {10.1002/ctm2.70885},
url = {https://onlinelibrary.wiley.com/doi/10.1002/ctm2.70885?af=R}
}
Nature Biomedical Engineering, Published online: 18 November 2026; doi:10.1038/s41551-026-01843-z Tumour-associated mucins induce the disassembly of a designer PEGylated paclitaxel-conjugated nanomedicine into small unimers that escape...